PubRank

I A Ramshaw

Author PubWeight™ 82.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996 5.38
2 Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 2001 4.98
3 The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994 2.53
4 Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 1998 2.37
5 Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol 1976 2.36
6 Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol 1974 2.23
7 IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 1999 2.05
8 A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 1993 2.02
9 Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol 1990 1.67
10 CD40 ligand has potent antiviral activity. Nat Med 1995 1.64
11 Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med 1990 1.56
12 Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol 1990 1.52
13 Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 1996 1.52
14 Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol 2004 1.39
15 Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol 1977 1.33
16 Lysis of herpesvirus-infected cells by immune spleen cells. Infect Immun 1975 1.32
17 Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci U S A 1991 1.22
18 Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med 1984 1.20
19 Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J Immunol 1991 1.16
20 Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol 1994 1.12
21 Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod 1998 1.12
22 DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol Cell Biol 1997 1.11
23 Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer 1987 1.11
24 Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol 1995 1.03
25 Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Res 1988 1.03
26 Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunol Rev 1999 1.02
27 Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol 2005 1.02
28 Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology 1996 1.01
29 Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice. Eur J Immunol 1977 1.00
30 Recombinant viruses as vaccines and immunological tools. Curr Opin Immunol 1997 1.00
31 Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. J Virol 1999 0.92
32 IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. J Immunol 1994 0.90
33 A requirement for helper T cells in the induction of delayed-type hypersensitivity. J Immunol 1983 0.90
34 A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. Scand J Immunol 2004 0.90
35 Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res 1992 0.90
36 T-cell mediated immunity towards antigen(s) on isologous erythrocytes. Nature 1977 0.88
37 A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. J Virol 1996 0.88
38 Growth of the IB-RS-2 pig kidney cell line in suspension culture and its susceptibility to foot-and-mouth disease virus. Appl Microbiol 1971 0.87
39 Cytokines in innate and adaptive immunity. Rev Immunogenet 2000 0.86
40 IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand J Immunol 2002 0.86
41 Lectin-binding characteristics of related high- and low-metastatic rat mammary adenocarcinoma cell lines. Invasion Metastasis 1987 0.86
42 The in vitro induction of T cells which mediate delayed-type hypersensitivity toward horse red blood cells. Cell Immunol 1979 0.85
43 Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. J Natl Cancer Inst 1990 0.85
44 Involvement of plasminogen activator production with tumor metastasis in a rat model. Cancer Res 1984 0.85
45 Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod Fertil Dev 1994 0.84
46 Surface properties of cells involved in antibody-dependent cytotoxicity. Cell Immunol 1976 0.83
47 The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer 1983 0.83
48 A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic. Int J Cancer 1982 0.83
49 Recombinant vaccine vector-induced protection of athymic, nude mice from influenza A virus infection. Analysis of protective mechanisms. Scand J Immunol 1992 0.82
50 Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells. Invasion Metastasis 1984 0.82
51 Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol 1983 0.82
52 DNA immunization. Immunol Cell Biol 1997 0.82
53 Effect of an iron-chelating agent on lymphocyte proliferation. Aust J Exp Biol Med Sci 1984 0.81
54 The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor. Cytokine 1995 0.81
55 Rejection of allogeneic tumor cells growing in mouse cerebrospinal fluid. Functional analysis of the inflammatory process. J Neuroimmunol 1981 0.80
56 Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma. J Med Primatol 2000 0.80
57 Immunology cross-reactivity between spinal cord protein and myelin basic protein. Int Arch Allergy Appl Immunol 1982 0.79
58 A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques. Vaccine 2000 0.79
59 Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation. Viral Immunol 1998 0.79
60 Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma. Invasion Metastasis 1986 0.78
61 Vaccinia-interleukin 2 recombinant virus or exogenous interleukin 2 does not alter the magnitude or immune response gene defects of the cytotoxic T-cell response to vaccinia virus in vivo. Scand J Immunol 1989 0.78
62 Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells. Appl Microbiol 1973 0.77
63 Studies on rat mammary adenocarcinomas: a model for metastasis. Cancer Metastasis Rev 1985 0.77
64 The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor. Arch Virol 1995 0.77
65 Characterisation of rat tumour cell hybrids: procoagulant and fibrinolytic activities. Aust J Exp Biol Med Sci 1985 0.77
66 The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies. Lymphokine Cytokine Res 1993 0.77
67 Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Res Immunol 1999 0.76
68 Analysis of mammary tumour cell metastasis and release of bound n-acetylneuraminic acid. Br J Cancer 1985 0.75
69 Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner. Viral Immunol 1997 0.75
70 The in vitro culture of spleen cells from mice expressing humoral immunity leads to the development of T cells that mediate delayed-type hypersensitivity. Cell Immunol 1981 0.75
71 Induction of suppressor T cells of antibody formation under conditions that preferentially stimulate DTH. J Immunol 1980 0.75
72 The in vitro suppression of spontaneous erythrocyte autoimmune responses with lymphocytes activated with concanavalin A. J Immunol 1979 0.75
73 One-way cross-reaction between spinal cord protein and myelin basic protein. Prog Clin Biol Res 1984 0.75
74 Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice. Microb Pathog 1991 0.75
75 Cytokine regulation of mucosal responses: a rational basis for new vaccine delivery strategies. Reprod Fertil Dev 1994 0.75
76 The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity. Biotechnol Ther 1994 0.75
77 Avipox virus vectors for gene delivery to fetal mouse and pig proislets. Transplant Proc 2000 0.75
78 Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor. Cancer Immunol Immunother 1985 0.75
79 A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic. Cancer Immunol Immunother 1987 0.75
80 Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells. Eur J Biochem 1986 0.75
81 Increased metastatic ability and bone formation of a mammary adenocarcinoma in vivo after in vitro passaging. Eur J Cancer Clin Oncol 1984 0.75
82 An inhibitor of plasminogen activator produced by tumour cell fusion hybrids. Aust J Exp Biol Med Sci 1985 0.75
83 Cytokine enhancement of immune responses important for immunocontraception. Reprod Fertil Dev 1997 0.75
84 One-way humoral immune cross-reactivity between bovine spinal cord protein and bovine myelin basic protein. Mol Immunol 1984 0.75
85 Cellular and secreted tumor plasminogen activator: the effects of NaCl. Experientia 1986 0.75
86 Enhanced antibody responses to antigens presented on autologous erythrocytes. J Immunol Methods 1977 0.75
87 A comparison of two radioimmunoassays for 7-hydroxychlorpromazine: rabbit polyclonal antibodies vs. mouse monoclonal antibodies. J Pharmacol Exp Ther 1985 0.75